The global lactose market is expected to reach USD 2.5 billion by 2030. Lactose is used as a carrier for drugs in inhalation and granulated form owing to its low cost and high solubility. Inhalation lactose has been used in the treatment of asthma, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, cystic fibrosis and other respiratory diseases. Granulated lactose has been used in the treatment of diabetes mellitus type 1 & 2 owing to its low glycemic index (GI) value which does not cause fluctuations in blood sugar levels after consumption. The global pharmaceutical lactose market can be segmented on the basis of type into crystalline monohydrate lactose, inhalation lactose, granulated lactose and spradried lactic acid; on the basis of application into hospital and pharmaceutical companies; on the basis of region into North America, Latin America Europe Asia Pacific Middle East & Africa (MEA). The North American region accounted for over 40% share of total revenue generated from sales across all regions during 2017-2030 period due to increased adoption rates among hospitals coupled with rising demand from pharmaceutical companies for various applications such as inhalation or granulated forms.
- The global pharmaceutical lactose market is expected to grow at a CAGR of 4.5% from 2017 to 2022.
- The increasing prevalence of lactose intolerance and the growing demand for dairy products are some of the factors driving the growth of this market.
- Lactose intolerance is an inability to digest lactose, which is found in milk and other dairy products due to insufficient levels of lactase enzyme in the body that breaks down lactose into glucose and galactose for absorption into bloodstreams.
Industry Growth Insights published a new data on “Pharmaceutical Lactose Market”. The research report is titled “Pharmaceutical Lactose Market research by Types (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray-dried Lactose), By Applications (Hospital, Pharmaceutical Companies, Others), By Players/Companies Merck, Meggle, Kerry Group, Amor Pharma, DFE Pharma, Farmers Co-operative Dairy, Norvatis, Bayer, Abbott”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Lactose Market Research Report
By Type
Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray-dried Lactose
By Application
Hospital, Pharmaceutical Companies, Others
By Companies
Merck, Meggle, Kerry Group, Amor Pharma, DFE Pharma, Farmers Co-operative Dairy, Norvatis, Bayer, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Lactose Market Report Segments:
The global Pharmaceutical Lactose market is segmented on the basis of:
Types
Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray-dried Lactose
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmaceutical Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Meggle
- Kerry Group
- Amor Pharma
- DFE Pharma
- Farmers Co-operative Dairy
- Norvatis
- Bayer
- Abbott
Highlights of The Pharmaceutical Lactose Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Crystalline Monohydrate Lactose
- Inhalation Lactose
- Granulated Lactose
- Spray-dried Lactose
- By Application:
- Hospital
- Pharmaceutical Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Lactose Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical lactose is a sugar that is used as a medication. It is often given to people who have trouble digesting other sugars.
Some of the major players in the pharmaceutical lactose market are Merck, Meggle, Kerry Group, Amor Pharma, DFE Pharma, Farmers Co-operative Dairy, Norvatis, Bayer, Abbott.
The pharmaceutical lactose market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Lactose Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Lactose Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Lactose Market - Supply Chain
4.5. Global Pharmaceutical Lactose Market Forecast
4.5.1. Pharmaceutical Lactose Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Lactose Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Lactose Market Absolute $ Opportunity
5. Global Pharmaceutical Lactose Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Lactose Market Size and Volume Forecast by Type
5.3.1. Crystalline Monohydrate Lactose
5.3.2. Inhalation Lactose
5.3.3. Granulated Lactose
5.3.4. Spray-dried Lactose
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Lactose Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Lactose Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Pharmaceutical Companies
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Lactose Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Lactose Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Lactose Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Lactose Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Lactose Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Lactose Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Lactose Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Lactose Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Pharmaceutical Companies
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Lactose Market Size and Volume Forecast by Type
9.7.1. Crystalline Monohydrate Lactose
9.7.2. Inhalation Lactose
9.7.3. Granulated Lactose
9.7.4. Spray-dried Lactose
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Lactose Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Lactose Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Lactose Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Lactose Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Pharmaceutical Companies
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Lactose Market Size and Volume Forecast by Type
10.7.1. Crystalline Monohydrate Lactose
10.7.2. Inhalation Lactose
10.7.3. Granulated Lactose
10.7.4. Spray-dried Lactose
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Lactose Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Lactose Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Lactose Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Lactose Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Pharmaceutical Companies
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Lactose Market Size and Volume Forecast by Type
11.7.1. Crystalline Monohydrate Lactose
11.7.2. Inhalation Lactose
11.7.3. Granulated Lactose
11.7.4. Spray-dried Lactose
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Lactose Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Lactose Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Lactose Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Lactose Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Pharmaceutical Companies
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Lactose Market Size and Volume Forecast by Type
12.7.1. Crystalline Monohydrate Lactose
12.7.2. Inhalation Lactose
12.7.3. Granulated Lactose
12.7.4. Spray-dried Lactose
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Lactose Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Lactose Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Lactose Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Lactose Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Pharmaceutical Companies
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Lactose Market Size and Volume Forecast by Type
13.7.1. Crystalline Monohydrate Lactose
13.7.2. Inhalation Lactose
13.7.3. Granulated Lactose
13.7.4. Spray-dried Lactose
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Lactose Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Lactose Market: Market Share Analysis
14.2. Pharmaceutical Lactose Distributors and Customers
14.3. Pharmaceutical Lactose Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Meggle
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Kerry Group
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Amor Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. DFE Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Farmers Co-operative Dairy
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Norvatis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bayer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Abbott
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook